BACKGROUND: Type 2 Gaucher disease is a rare and progressive subtype of this lysosomal storage disorder, marked by rapid, early-onset neurodegeneration. Distinguishing type 2 from types 1 and 3 Gaucher disease has remained challenging, due to the lack of a clear correlation between phenotype and enzymatic activity or genotype. β-glucocerebrosidase, the enzyme deficient in Gaucher disease, also has an essential role in maintaining epidermal permeability function, by regulating the ratio of ceramides to glucosylceramides in the stratum corneum of the skin. OBJECTIVES: To further assess the diagnostic utility of epidermal evaluations in distinguishing patients with type 2 Gaucher disease in an expanded cohort. STUDY DESIGN: Epidermal samples were evaluated from twenty children with type 2, three patients with type 3 Gaucher disease and two adults with type 1 Gaucher disease with different clinical manifestations and genotypes. Electron microscopy on ruthenium tetroxide post-fixed tissue was performed. RESULTS: Compared to controls and subjects with type 1 and type 3 Gaucher disease, only patients with type 2 Gaucher disease displayed characteristic electron dense, non-lamellar clefts and immature-lamellar membranes. CONCLUSION: The appearance of characteristic alterations in epidermal ultrastructure provides an early and specific diagnostic tool to help in distinguishing type 2 from the other types of Gaucher disease.
BACKGROUND:Type 2 Gaucher disease is a rare and progressive subtype of this lysosomal storage disorder, marked by rapid, early-onset neurodegeneration. Distinguishing type 2 from types 1 and 3 Gaucher disease has remained challenging, due to the lack of a clear correlation between phenotype and enzymatic activity or genotype. β-glucocerebrosidase, the enzyme deficient in Gaucher disease, also has an essential role in maintaining epidermal permeability function, by regulating the ratio of ceramides to glucosylceramides in the stratum corneum of the skin. OBJECTIVES: To further assess the diagnostic utility of epidermal evaluations in distinguishing patients with type 2 Gaucher disease in an expanded cohort. STUDY DESIGN: Epidermal samples were evaluated from twenty children with type 2, three patients with type 3 Gaucher disease and two adults with type 1 Gaucher disease with different clinical manifestations and genotypes. Electron microscopy on ruthenium tetroxide post-fixed tissue was performed. RESULTS: Compared to controls and subjects with type 1 and type 3 Gaucher disease, only patients with type 2 Gaucher disease displayed characteristic electron dense, non-lamellar clefts and immature-lamellar membranes. CONCLUSION: The appearance of characteristic alterations in epidermal ultrastructure provides an early and specific diagnostic tool to help in distinguishing type 2 from the other types of Gaucher disease.
Authors: V L Tybulewicz; M L Tremblay; M E LaMarca; R Willemsen; B K Stubblefield; S Winfield; B Zablocka; E Sidransky; B M Martin; S P Huang Journal: Nature Date: 1992-06-04 Impact factor: 49.962
Authors: Y Uchida; M Hara; H Nishio; E Sidransky; S Inoue; F Otsuka; A Suzuki; P M Elias; W M Holleran; S Hamanaka Journal: J Lipid Res Date: 2000-12 Impact factor: 5.922
Authors: Nahid Tayebi; Barbara K Stubblefield; Joseph K Park; Eduard Orvisky; Jamie M Walker; Mary E LaMarca; Ellen Sidransky Journal: Am J Hum Genet Date: 2003-02-13 Impact factor: 11.025
Authors: Ozlem Goker-Alpan; Raphael Schiffmann; Joseph K Park; Barbara K Stubblefield; Nahid Tayebi; Ellen Sidransky Journal: J Pediatr Date: 2003-08 Impact factor: 4.406
Authors: S Tsuji; P V Choudary; B M Martin; B K Stubblefield; J A Mayor; J A Barranger; E I Ginns Journal: N Engl J Med Date: 1987-03-05 Impact factor: 91.245
Authors: Elizabeth A Mauldin; Debra Crumrine; Margret L Casal; Sekyoo Jeong; Lukáš Opálka; Katerina Vavrova; Yoshikazu Uchida; Kyungho Park; Brittany Craiglow; Keith A Choate; Kyong-Oh Shin; Yong-Moon Lee; Gary L Grove; Joan S Wakefield; Denis Khnykin; Peter M Elias Journal: Am J Pathol Date: 2018-03-13 Impact factor: 4.307